ArticleACS medicinal chemistry letters2026

Cannabinol β‑O-Glucoside Inhibitors of the Keap1-Nrf2 Interaction: A Novel Therapeutic Strategy for Parkinson's Disease.

Prashant Deshmukh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.